Amicus Therapeutics (FOLD) EPS (Weighted Average and Diluted): 2009-2025
Historic EPS (Weighted Average and Diluted) for Amicus Therapeutics (FOLD) over the last 4 years, with Sep 2025 value amounting to $0.06.
- Amicus Therapeutics' EPS (Weighted Average and Diluted) rose 400.00% to $0.06 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.04, marking a year-over-year increase of 88.24%. This contributed to the annual value of -$0.18 for FY2024, which is 64.71% up from last year.
- According to the latest figures from Q3 2025, Amicus Therapeutics' EPS (Weighted Average and Diluted) is $0.06, which was up 175.00% from -$0.08 recorded in Q2 2025.
- In the past 5 years, Amicus Therapeutics' EPS (Weighted Average and Diluted) ranged from a high of $0.06 in Q3 2025 and a low of -$0.31 during Q4 2021.
- Moreover, its 3-year median value for EPS (Weighted Average and Diluted) was -$0.07 (2025), whereas its average is -$0.07.
- Within the past 5 years, the most significant YoY rise in Amicus Therapeutics' EPS (Weighted Average and Diluted) was 400.00% (2025), while the steepest drop was 60.00% (2025).
- Quarterly analysis of 5 years shows Amicus Therapeutics' EPS (Weighted Average and Diluted) stood at -$0.31 in 2021, then surged by 37.01% to -$0.19 in 2022, then surged by 43.08% to -$0.11 in 2023, then skyrocketed by 145.45% to $0.05 in 2024, then spiked by 400.00% to $0.06 in 2025.
- Its EPS (Weighted Average and Diluted) stands at $0.06 for Q3 2025, versus -$0.08 for Q2 2025 and -$0.07 for Q1 2025.